论文信息 - Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance - 字舞流文

Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance

C. Crews | T. Neklesa | D. McDonnell | Ryan R. Willard | Hanqing Dong | Jing Wang | A. Crew | J. Salami | Shanique Alabi | N. Vitale | Meizhong Jin